Emotional eaters may see fewer results from blockbuster weight loss drugs like Ozempic, a study suggests. Researchers in Japan tracked nearly 100 people with type 2 diabetes over the course of their first year taking GLP-1 agonists like Ozempic, Wegovy and Mounjaro. At three different points they collected data on the patients’ weight, diet and blood markers like glucose and …
Read More »
Weight loss surgery is a cheaper and more effective way than medications like Ozempic for obese patients to shed pounds, according to a Highmark Health study released Wednesday that tracked thousands of people. Patients with severe obesity lost 28% of their weight on average, compared to just 10% with the GLP-1 class of drugs. Surgeries were tied to 18% lower …
Read More »
GLP-1 agonists—so-called “wonder drugs” like Ozempic or Wegovy that help individuals lower blood sugar levels and lose weight, among other things—yield significant results for some patients, but not all. People’s motivations to overeat may play a role in this, according to a new study. To investigate why some people don’t benefit from GLP-1 agonists as much as others, researchers observed …
Read More »
If there were a “drug of the summer” award, Ozempic would win hands down. This Glucagon-Like Peptide 1 (GLP-1) receptor agonist, scientifically known as Semaglutide, was originally developed to treat type 2 diabetes. Today, it’s better known for delivering rapid, dramatic weight loss. But Ozempic’s meteoric rise has brought increased scrutiny. Its manufacturer, Novo Nordisk, now faces a flood of …
Read More »
An Australian analysis of more than a million primary-care records suggests many women of reproductive age starting GLP-1 receptor agonists for weight loss aren’t using effective contraception, despite potential pregnancy risks. Credit: Stock Researchers warn that widespread use of weight-loss drugs like Ozempic among women of reproductive age may pose hidden risks to pregnancy. Flinders University researchers caution that many …
Read More »
Research on the microbes living in our digestive tract has triggered a ‘revolution‘ in nutritional science. In the last few years, dietary fiber has become the “new protein“, added to foods in abundance to feed our gut’s microbiome and boost our health. However, a study on mice published in 2024 suggests that not all fiber supplements are equally beneficial. Related: …
Read More »Ozempic Maker Novo Nordisk to Cut 9,000 Jobs, Around 11% of Workforce The Wall Street Journal Ozempic maker Novo Nordisk to cut 11% of workforce Quartz Trump reportedly asks EU to levy 100% tariffs on India and China; Ozempic maker Novo to cut 9,000 jobs – as it happened The Guardian Novo Nordisk job cuts a necessary reset after hypergrowth, analysts say CNBC Wegovy …
Read More »Ozempic Maker Novo Nordisk to Cut 9,000 Jobs The New York Times Wegovy-maker Novo Nordisk to cut around 9,000 jobs CNBC Novo Tries to Catch Up With Lilly by Slashing 11% of Workforce Bloomberg Ozempic maker Novo Nordisk is cutting 9,000 jobs AP News Novo Nordisk slashes 9,000 jobs to slim down in fierce weight-loss drug battle Reuters Source link
Read More »Ozempic Maker Novo Nordisk to Slash 9,000 Jobs The Wall Street Journal Wegovy-maker Novo Nordisk to slash 9,000 jobs as competition heats up Reuters Novo to Cut 11% of Workforce as New CEO Slashes Forecast Bloomberg.com Novo Nordisk, maker of obesity drug Wegovy, to cut 9,000 jobs to sharpen focus, meet competition Yahoo Finance Wegovy-maker Novo Nordisk to cut around 9,000 jobs CNBC Source link
Read More »
Scientists think they may have developed a new weight loss drug that is more than twice as effective as Ozempic with fewer negative side effects. GLP-1 injectable medications, which include Ozempic, Wegovy and Mounjaro, mimic natural glucagon-like peptide-1 (GLP-1), a hormone that regulates appetite and metabolism. Depending on the drug, they can target either one, two or three hormones. They work …
Read More »